Navigation Links
Cimzia® (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthritis Patients
Date:5/10/2011

tions

Rare reports of pancytopenia, including aplastic anemia, have been reported with TNF blockers.  Medically significant cytopenia (e.g., leukopenia, pancytopenia, thrombocytopenia) has been infrequently reported with certolizumab pegol.  Advise all patients to seek immediate medical attention if they develop signs and symptoms suggestive of blood dyscrasias or infection (e.g., persistent fever, bruising, bleeding, pallor) while on certolizumab pegol.  Consider discontinuation of certolizumab pegol therapy in patients with confirmed significant hematologic abnormalities.

Drug Interactions

An increased risk of serious infections has been seen in clinical trials of other TNF blocking agents used in combination with anakinra or abatacept.  Formal drug interaction studies have not been performed with rituximab or natalizumab; however because of the nature of the adverse events seen with these combinations with TNF blocker therapy, similar toxicities may also result from the use of certolizumab pegol in these combinations.  Therefore, the combination of certolizumab pegol with anakinra, abatacept, rituximab, or natalizumab is not recommended.  Interference with certain coagulation assays has been detected in patients treated with certolizumab pegol.  There is no evidence that certolizumab pegol therapy has an effect on in vivo coagulation.  Certolizumab pegol may cause erroneously elevated aPTT assay results in patients without coagulation abnormalities.

Autoimmunity

Treatment with certolizumab pegol may result in the formation of autoantibodies and, rarely, in the development of a lupus-like syndrome.  Discontinue treatment if symptoms of lupus-like syndrome develop.

Immunizations

Do not administer live vaccines or attenuated vaccines concurrently with certolizumab pegol.

'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
2. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
3. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
4. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
5. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
6. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
7. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
8. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
9. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
10. New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation
11. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013  Cataracts are the leading cause of ... of Ophthalmology, aging is the leading cause of eye ... natural lens. 22 million Americans age 40 and older ... to age, that number will increase over 30 million. ... iPads, smart-phones and computers, the demographic of ages 40 ...
(Date:6/18/2013)... , June 18, 2013  In a letter to ... , M.D., of Lake View, Iowa , ... receive annual influenza vaccine is neither scientifically justified nor ethically ... article in the summer issue of the Journal ... official statistics are correct, and an average of 36,000 patients ...
(Date:6/18/2013)... 2013 Decision Resources, one of the world,s leading ... that, over the past 12 months, 25 percent of surveyed ... Germany , Italy , ... ) have been required to change the antiretroviral (ARV) ... to reduce costs. Additionally, more than 40 percent of respondents ...
Breaking Medicine Technology:New Vision Hope For Millions Undergoing Cataract Surgery 2New Vision Hope For Millions Undergoing Cataract Surgery 3Mandated Flu Vaccine for Hospital Workers Ethically Questionable, Surgeon Writes 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3
... China, April 19, 2011 /PRNewswire-Asia-FirstCall/ -- China Botanic ... ("China Botanic" or the "Company"), a developer, manufacturer ... Chinese medicines ("TCM") in China, today announced that ... owned subsidiary, Harbin Renhuang Pharmaceutical Co., Ltd ("Renhuang"), ...
... Henry Schein, Inc. (Nasdaq: HSIC ), the largest ... announced today that it will release its first quarter 2011 ... 3, 2011, and will provide a live webcast of its ... a.m. Eastern Daylight Time. Speakers on the call will include ...
Cached Medicine Technology:China Botanic Pharmaceutical Provides Update on Badger Oil Sales 2China Botanic Pharmaceutical Provides Update on Badger Oil Sales 3Henry Schein to Webcast First Quarter 2011 Conference Call Tuesday, May 3, at 10:00 a.m. EDT 2
(Date:6/18/2013)... Senior drug regulatory officials from mainland China and ... the first time in the U.S.—the need for more collaboration ... process in a timely manner. Representatives from the Taiwan and ... practices and processes in drug review during the Convergence ... DIA 2013 49th Annual Meeting . , ...
(Date:6/18/2013)... 18, 2013 Sun Buick GMC, Moosic, is ... Services 20th Annual Golf Tournament on Thursday, June 20, at ... prize is a 2013 Buick Verano and will go to ... hole-in-one on Irem’s 7th hole. , The MFHS golf tournament ... a four person captain and crew team for 18 holes. ...
(Date:6/18/2013)... researchers have launched an innovative clinical trial, unique ... of a patient,s own stem cells to prevent ... (PAD). , Led by Vik Kashyap, MD, ... Medical Center,s Harrington Heart & Vascular Institute and ... School of Medicine, the clinical trial is designed ...
(Date:6/18/2013)... The July 2013 issue of Marie Claire magazine ... Ready,” offers a list of home and doctor’s office treatments ... bathing suit this summer. The list includes treatment options for ... cellulite , and more. (go to goo.gl/aIe4J). , “It’s a ... Beverly Hills, “though I would say some of the advice ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 ... Care, ScripNet and Procura Management, today announced the ... chief sales officer. In this position, Leonardo will ... of the company’s strategic growth initiatives. , Recognized ... leadership and expertise, Leonardo brings more than 20 ...
Breaking Medicine News(10 mins):Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Skin Care – Getting Your Body Beach Ready 2Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2
... Mich., Jan. 30 Stryker Corporation,(NYSE: SYK ) announced today ... February 6, 2008 - 2:20 p.m. Eastern Time ... and Medical Device Conference ... of the Company,s presentation will be available,on Stryker,s website at ...
... today in FASEB (the journal of the Federation of ... University, including Jeremy Mao of the Columbia College of ... structures as a drug-delivery vehicle that can help boost ... , Instead of being acted upon by the body ...
... potentially life-threatening disease that affects red blood cells, cells ... part of the SardiNIA Study of Aging, supported by ... the National Institutes of Health, scientists have found a ... why some people with beta-thalassemia seem to be protected ...
... published this week in the online version of Biophysical Journal ... ion channels. This new understanding of the channels that control ... piece of the molecular puzzle. , The work of experts ... a new explanation for how ion channels open and close. ...
... 7,000 unique seed samples from more than 36 African ... a facility being built on a remote island in ... for humanitys agricultural heritage. , The vault is being ... the global community, and a Rome-based international NGO, the ...
... the bog outshines 19 commonly eaten fruits for ... The latest,Agricultural Research Service Report from USDA, containing ... in foods, shows cranberries,score among the highest of ... )., The report includes antioxidant values for ...
Cached Medicine News:Health News:Stryker to Present at Investor Conference 2Health News:Porous structures help boost integration of host tissue with implants, study finds 2Health News:Gene variant linked to moderated symptoms of beta-thalassemia 2Health News:Revolution in understanding of ion channel regulation 2Health News:African seed collection first to arrive in Norway on route to Arctic seed vault 2Health News:African seed collection first to arrive in Norway on route to Arctic seed vault 3Health News:Cranberries' Antioxidant Level Tops List in USDA Report 2Health News:Cranberries' Antioxidant Level Tops List in USDA Report 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: